Successful rechallenge of bevacizumab after grade 4 bevacizumab induced hypertension in a case of carcinoma ovary, is rechallenging an option? - A Rare case report
Crossref DOI link: https://doi.org/10.30574/gscbps.2022.18.3.0161
Published Online: 2022-03-30
Update policy: https://doi.org/10.30574/gscbps.ourcrossmarkpolicy
Satish sharma,
Apurva A patel,
Aruj Dhyani,
Nikesh Aggarwal,
Yuganshi Gupta,
Goutham R Reddy,
Debajyoti Maji,
Harshvardhan A,
Phillip G Kuttikat,
Ananya Pareek,
Sonia Parikh,
Harsha P Panchal,
